Quest Diagnostics Incorporated (NYSE: DGX) announced that its Board of Directors increased the company's share repurchase authorization by $750 million.
This article: 111 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE